2026年7月6日，江苏中慧元通生物科技股份有限公司（“中慧生物-B”，股票代码：02627）发布了截至2026年6月30日的股份变动月报表。报告期内，公司股本结构保持稳定，未发生新增发行、购回、注销或库藏股等变动。
截至6月30日，公司法定注册股本为人民币393,442,600元，其中包括296,361,845股H股（每股面值人民币1元）和97,080,755股内资股（每股面值人民币1元），合计已发行股份数为393,442,600股。报告显示，当月没有新增股份发行、购回或注销活动，公司股本规模与上月底相比无变化。此外，当月并无股票期权或股权激励计划的授出、行使或失效记录。
公司同时在公告中确认已遵守香港联合交易所有限公司上市规则及相关法律规定。公告由执行董事李润香签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.